Track the 吉贝尔 share price and the full insider trade history of the company, a listed equity based in China. Shares trade on CN CN, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 吉贝尔 has logged 9 insider filings. Market capitalisation: €6bn. The latest transaction was reported on 18 July 2025 (Sale). Among the most active insiders: 吴修艮. The full history is free.
9
Insider Decl.
0
Thresholds
·
1 ops.
Buy Volume
·
8 ops.
Sell Volume
7Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 4,800 of 25,571 companies
67.7
score / 100
Value
49
Quality
86
FCF yld2.5%
Earn yld4.9%
EV/EBITDA16.7x
ROE11%
Gross mgn89%
Net mgn27%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.